{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:45:54Z","timestamp":1762875954936},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","amjmedsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.amjms.2018.01.008","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T17:05:53Z","timestamp":1517418353000},"page":"181-184","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Recurrent Severe Hypoinsulinemic Hypoglycemia Responsive to Temozolomide and Bevacizumab in a Patient With Doege-Potter Syndrome"],"prefix":"10.1016","volume":"356","author":[{"given":"Amie A.","family":"Ogunsakin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly L.","family":"Hilsenbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Portnoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebenezer A.","family":"Nyenwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2018.01.008_bib1","first-page":"955","article-title":"Fibrosarcoma of the mediastinum","volume":"92","author":"Doege","year":"1930","journal-title":"Ann Surg"},{"key":"10.1016\/j.amjms.2018.01.008_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1148\/14.1.60","article-title":"Intrathoracic tumours. Case report","volume":"14","author":"Potter","year":"1930","journal-title":". Radiology"},{"key":"10.1016\/j.amjms.2018.01.008_bib3","first-page":"588","article-title":"Solitary fibrous tumor of the pleura with associated hypoglycemia: Doege-Potter syndrome: a case report","volume":"1","author":"Balduyck","year":"2006","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.amjms.2018.01.008_bib4","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1002\/1097-0142(19810601)47:11<2678::AID-CNCR2820471126>3.0.CO;2-9","article-title":"Solitary fibrous tumor of the pleura: eight new cases and review of 360 cases in the literature","volume":"47","author":"Briselli","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.amjms.2018.01.008_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1749-8090-4-45","article-title":"Surgically cured hypoglycemia secondary to pleural solitary fibrous tumour: case report and update review on the Doege-Potter syndrome","volume":"4","author":"Kalebi","year":"2009","journal-title":"J Cardiothoracic Surg"},{"key":"10.1016\/j.amjms.2018.01.008_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-5223(00)70242-X","article-title":"Solitary fibrous tumor associated with hypoglycemia: an example of the Doege-Potter syndrome","volume":"119","author":"Chamberlain","year":"2000","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"11","key":"10.1016\/j.amjms.2018.01.008_bib7","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.5858\/2010-0086-RAR.1","article-title":"Sarcomatoid neoplasms of the lung and pleura","volume":"vol. 134","author":"Travis","year":"2010","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"10.1016\/j.amjms.2018.01.008_bib8","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/modpathol.2012.83","article-title":"Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model","volume":"vol. 25","author":"Demicco","year":"2012","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.amjms.2018.01.008_bib9","first-page":"99","article-title":"Thoracic malignant solitary fibrous tumours: a population-based study of survival","volume":"vol. 3","author":"Milano","year":"2011","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.amjms.2018.01.008_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1749-8090-9-113","article-title":"Malignant solitary fibrous tumor of the pleura slowly growing over 17 years: case report","volume":"vol. 9","author":"Jeon","year":"2014","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.amjms.2018.01.008_bib11","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/00000478-199408000-00008","article-title":"Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum, and lung","volume":"18","author":"Van de Rijn","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.amjms.2018.01.008_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1365-2559.1998.00412.x","article-title":"Solitary fibrous tumour (significance of p53 and CD34 immunoreactivity in its malignant transformation)","volume":"32","author":"Yokoi","year":"1998","journal-title":"Histopathology"},{"key":"10.1016\/j.amjms.2018.01.008_bib13","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1172\/JCI116152","article-title":"Can \u201cbig\u201d insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?","volume":"90","author":"Zapf","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjms.2018.01.008_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1677\/joe.0.1650253","article-title":"Binding characteristics of pro-insulin-like growth factor-II from cancer patients: binary et ternary complex formation with IGF binding proteins-1 and 6","volume":"165","author":"Bond","year":"2000","journal-title":"J Endocrinol"},{"key":"10.1016\/j.amjms.2018.01.008_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1472-6823-14-49","article-title":"Hypoglycemia mediated by paraneoplastic production of Insulin like growth factor-2 from a malignant renal solitary fibrous tumor\u2014clinical case and literature review","volume":"14","author":"Khowaja","year":"2014","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.amjms.2018.01.008_bib16","first-page":"919","article-title":"Mechanisms of tumor-induced hypoglycemia with intrabdominal hemangiopericytoma","volume":"81","author":"Chung","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjms.2018.01.008_bib17","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1530\/eje.0.1390532","article-title":"Dose-related effects of growth hormone on IGF-I and IGF-binding protein-3 levels in non-islet cell tumour hypoglycaemia","volume":"139","author":"Drake","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.amjms.2018.01.008_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1365-2265.1998.00564.x","article-title":"Glucocorticoid therapy suppresses abnormal secretion of big IGF-II by non-islet cell tumours inducing hypoglycaemia (NICTH)","volume":"49","author":"Teale","year":"1998","journal-title":"Clin Endocrinol"},{"issue":"10","key":"10.1016\/j.amjms.2018.01.008_bib19","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10<1915::AID-CNCR15>3.0.CO;2-W","article-title":"Management of recurrent meningeal hemangiopericytoma","volume":"82","author":"Galanis","year":"1998","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.amjms.2018.01.008_bib20","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1227\/01.NEU.0000325494.69836.51","article-title":"Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma","volume":"63","author":"Chamberlain","year":"2008","journal-title":"Neurosurgery"},{"issue":"7","key":"10.1016\/j.amjms.2018.01.008_bib21","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/cncr.20109","article-title":"Intracranial meningeal hemangiopericytoma: the role of radiotherapy: report of 29 cases and review of the literature","volume":"100","author":"Soyuer","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.amjms.2018.01.008_bib22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/CCO.0b013e32832c9532","article-title":"New insights into the hemangiopericytoma\/solitary fibrous tumor spectrum of tumors","volume":"21","author":"Park","year":"2009","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.amjms.2018.01.008_bib23","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1200\/JCO.2008.20.4495","article-title":"Phase II study of sorafenib in patients with metastatic or recurrent sarcomas","volume":"27","author":"Maki","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjms.2018.01.008_bib24","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1002\/cncr.26098","article-title":"Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor","volume":"vol. 117","author":"Park","year":"2011","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.amjms.2018.01.008_bib25","first-page":"199","article-title":"Role of DTIC (NSC-45388) in the chemotherapy of sarcomas","volume":"60","author":"Gottlieb","year":"1976","journal-title":"Cancer Treat Rep"},{"issue":"9","key":"10.1016\/j.amjms.2018.01.008_bib26","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/cncr.11730","article-title":"A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcoma","volume":"98","author":"Talbot","year":"2003","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.amjms.2018.01.008_bib27","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/cncr.11875","article-title":"A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas","volume":"98","author":"Trent","year":"2003","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.amjms.2018.01.008_bib28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc2403","article-title":"VEGF-targeted therapy: mechanisms of anti-tumour activity","volume":"8","author":"Ellis","year":"2008","journal-title":"Nat Rev Cancer"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962918300120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962918300120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T17:39:07Z","timestamp":1660412347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962918300120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0002962918300120"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2018.01.008","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent Severe Hypoinsulinemic Hypoglycemia Responsive to Temozolomide and Bevacizumab in a Patient With Doege-Potter Syndrome","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2018.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Southern Society for Clinical Investigation. Published by All rights reserved.","name":"copyright","label":"Copyright"}]}}